Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NOVOCART 3D plus versus microfracture for knee cartilage defects
2011-005798-22Phase 3Completed
- Sponsor
- TETEC AG
- Start
- Apr 2012
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of NOVOCART 3D in cartilage defect of knee and Knee cartilage injury (2 arms), sponsored by TETEC AG. Started Apr 2012; status: completed.
02
Drugs
NOVOCART 3D
03
Conditions
cartilage defect of kneeKnee cartilage injury
Beyond the preview
Go deeper on 2011-005798-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-005798-22.